CHRS ▲ +11.2% - Coherus Oncology, Inc.
$CHRS - Coherus Oncology Announces Compelling Tagmokitug Interim Clinical Data in Esophageal Cancer and Path to Advance Development
28-OCT-2026 04:05 PM ET
Share this post
More filings for $CHRS
CHRS ▲ +2.0% - Coherus Oncology, Inc.Oct 27, 2026CHRS ▼ -1.9% - Coherus Oncology, Inc.Oct 14, 2026$CHRS SEC Filing Update (27-JUL-2026) | ThinkSabio - Stocks SimplifiedJul 27, 2026
View full $CHRS filing history →💬 Comments
Loading comments…
Leave a comment